Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of TAK-438, once daily (QD), compared
to lansoprazole in patients with erosive esophagitis of Grade A to D as defined by the LA
classification grading system.